These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15458694)

  • 1. Ischemic preconditioning: emerging evidence, controversy, and translational trials.
    Sanada S; Kitakaze M
    Int J Cardiol; 2004 Nov; 97(2):263-76. PubMed ID: 15458694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic preconditioning. Experimental facts and clinical perspective.
    Post H; Heusch G
    Minerva Cardioangiol; 2002 Dec; 50(6):569-605. PubMed ID: 12473980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning.
    Schwarz ER; Whyte WS; Kloner RA
    Curr Opin Cardiol; 1997 Sep; 12(5):475-81. PubMed ID: 9352175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping preconditioning's signaling pathways: an engineering approach.
    Downey JM; Krieg T; Cohen MV
    Ann N Y Acad Sci; 2008 Mar; 1123():187-96. PubMed ID: 18375591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic preconditioning: from molecular characterisation to clinical application--part I.
    Riksen NP; Smits P; Rongen GA
    Neth J Med; 2004 Nov; 62(10):353-63. PubMed ID: 15683090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adaptation of myocardium to ischemia. The early phase of ischemic preconditioning].
    Maslov LN; Lishmanov IuB; Solenkova NV
    Usp Fiziol Nauk; 2006; 37(3):25-41. PubMed ID: 17022466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.
    Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes.
    Pan TT; Feng ZN; Lee SW; Moore PK; Bian JS
    J Mol Cell Cardiol; 2006 Jan; 40(1):119-30. PubMed ID: 16325198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart.
    Depre C; Wang L; Sui X; Qiu H; Hong C; Hedhli N; Ginion A; Shah A; Pelat M; Bertrand L; Wagner T; Gaussin V; Vatner SF
    Circ Res; 2006 Feb; 98(2):280-8. PubMed ID: 16373598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms.
    Hanley PJ; Daut J
    J Mol Cell Cardiol; 2005 Jul; 39(1):17-50. PubMed ID: 15907927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin mimics ischemic preconditioning.
    Baker JE
    Vascul Pharmacol; 2005; 42(5-6):233-41. PubMed ID: 15922256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial preconditioning and cardioprotection by volatile anaesthetics.
    Siracusano L; Girasole V; Alvaro S; Chiavarino ND
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):86-95. PubMed ID: 16645367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic preconditioning decreases the reperfusion-related formation of hydroxyl radicals in a rabbit model of regional myocardial ischemia and reperfusion: the role of K(ATP) channels.
    Raphael J; Drenger B; Rivo J; Berenshtein E; Chevion M; Gozal Y
    Free Radic Res; 2005 Jul; 39(7):747-54. PubMed ID: 16036354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of acetylcholine- and bradykinin-induced preconditioning.
    Critz SD; Cohen MV; Downey JM
    Vascul Pharmacol; 2005; 42(5-6):201-9. PubMed ID: 15922253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically useful cardioprotection: ischemic preconditioning then and now.
    Vander Heide R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):251-4. PubMed ID: 21821524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):821-31. PubMed ID: 16242951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitric oxide during early phase myocardial ischemic preconditioning in rats.
    Han HG; Wang ZW; Zhang NB; Zhu HY
    Chin Med J (Engl); 2008 Jul; 121(13):1210-4. PubMed ID: 18710640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.